Suppr超能文献

摩洛哥非综合征性听力损失患者线粒体A1555G突变的患病率

Prevalence of the mitochondrial A 1555G mutation in Moroccan patients with non-syndromic hearing loss.

作者信息

Nahili Halima, Charif Majida, Boulouiz Redouane, Bounaceur Safaa, Benrahma Houda, Abidi Omar, Chafik Abdelaziz, Rouba Hassan, Kandil Mostafa, Barakat Abdelhamid

机构信息

Laboratoire de Génétique Moléculaire et Humaine, Département de Recherche Scientifique, Institut Pasteur, Place Louis Pasteur, 20360 Casablanca, Morocco.

出版信息

Int J Pediatr Otorhinolaryngol. 2010 Sep;74(9):1071-4. doi: 10.1016/j.ijporl.2010.06.008. Epub 2010 Jul 15.

Abstract

UNLABELLED

Mutations in mitochondrial DNA (mtDNA), especially the A1555G transition in the 12S rRNA gene, are one of the causes of both aminoglycoside-induced and non-syndromic sensorineural hearing loss.

OBJECTIVE

The aim of this study was to determine the prevalence of the A1555G mitochondrial mutation in Moroccan patients.

METHODS

We performed molecular characterization by PCR-RFLP and direct sequencing of one hundred and sixty four patients (84 unrelated familial and 80 sporadic cases) with a congenital sensorineural non-syndromic hearing loss and one hundred normal hearing controls for the occurrence of the A1555G mutation.

RESULTS

Mutational analysis of the mtDNA showed the presence of the homoplasmic A1555G mutation in three families, leading to a frequency of 3.6% similar to that reported for European-populations. No A1555G mutation was detected in sporadic and controls cases. However, we detected in twenty normal hearing controls a novel polymorphism A1557C, which was not found in patient samples. We further evidenced the presence of the A1438G mitochondrial polymorphism in four patients with sensorineural hearing loss and in five controls.

CONCLUSION

Our results show that the occurrence of the A1555G mutation in hearing impaired patient's accounts for 3.6% in a Moroccan patients and those novel mtDNA polymorphisms might contribute to a novel sub-haplogroup specific of the Magrheb.

摘要

未标注

线粒体DNA(mtDNA)突变,尤其是12S rRNA基因中的A1555G转换,是氨基糖苷类药物所致和非综合征性感音神经性听力损失的病因之一。

目的

本研究旨在确定摩洛哥患者中A1555G线粒体突变的患病率。

方法

我们采用PCR-RFLP和直接测序法对164例先天性非综合征性感音神经性听力损失患者(84例非亲缘家族性和80例散发性病例)以及100例听力正常对照者进行分子特征分析,以检测A1555G突变的发生情况。

结果

mtDNA的突变分析显示,在三个家族中存在纯合性A1555G突变,频率为3.6%,与欧洲人群报道的频率相似。在散发性病例和对照病例中未检测到A1555G突变。然而,我们在20例听力正常对照者中检测到一种新的多态性A1557C,在患者样本中未发现。我们进一步证实,在4例感音神经性听力损失患者和5例对照者中存在A1438G线粒体多态性。

结论

我们的结果表明,听力受损患者中A1555G突变的发生率在摩洛哥患者中为3.6%,这些新的mtDNA多态性可能有助于确定马格里布地区特有的一个新的亚单倍群。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验